IRIS Accounts Production v23.3.0.418 11972936 Board of Directors 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119729362022-05-31119729362023-05-31119729362022-06-012023-05-31119729362021-05-31119729362021-06-012022-05-31119729362022-05-3111972936ns10:Originalns15:EnglandWales2022-06-012023-05-3111972936ns14:PoundSterlingns10:Original2022-06-012023-05-3111972936ns10:Originalns10:Director12022-06-012023-05-3111972936ns10:Original2022-06-012023-05-3111972936ns10:Original2023-05-3111972936ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3111972936ns10:Originalns10:SmallEntities2022-06-012023-05-3111972936ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3111972936ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3111972936ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3111972936ns10:Originalns10:FullAccounts2022-06-012023-05-3111972936ns10:Originalns10:Director22022-06-012023-05-3111972936ns10:Originalns10:RegisteredOffice2022-06-012023-05-3111972936ns10:Original2022-05-3111972936ns10:Originalns5:CurrentFinancialInstruments2023-05-3111972936ns10:Originalns5:CurrentFinancialInstruments2022-05-3111972936ns10:Originalns5:Non-currentFinancialInstruments2023-05-3111972936ns10:Originalns5:Non-currentFinancialInstruments2022-05-3111972936ns5:ShareCapitalns10:Original2023-05-3111972936ns5:ShareCapitalns10:Original2022-05-3111972936ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3111972936ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3111972936ns10:Originalns5:PlantMachinery2022-06-012023-05-3111972936ns10:Original2021-06-012022-05-3111972936ns10:Originalns5:PlantMachinery2022-05-3111972936ns10:Originalns5:PlantMachinery2023-05-3111972936ns10:Originalns5:PlantMachinery2022-05-3111972936ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3111972936ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-31
REGISTERED NUMBER: 11972936 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2023

FOR

ARISTO HEALTH LTD

ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ARISTO HEALTH LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2023







DIRECTORS: A J Sadeh
S S A Sam-Daliri





REGISTERED OFFICE: 528 Wimborne Road
Bournemouth
Dorset
BH9 2EX





REGISTERED NUMBER: 11972936 (England and Wales)





ACCOUNTANTS: Chorus Accounting Limited
9a & 10a Saxon Square
Christchurch
Dorset
BH23 1QA

ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)

BALANCE SHEET
31 MAY 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 4 2,311 2,011

CURRENT ASSETS
Debtors 5 77,142 56,568
Cash at bank 2,591 8,818
79,733 65,386
CREDITORS
Amounts falling due within one year 6 (43,741 ) (32,468 )
NET CURRENT ASSETS 35,992 32,918
TOTAL ASSETS LESS CURRENT LIABILITIES 38,303 34,929

CREDITORS
Amounts falling due after more than one
year

7

(79,667

)

(88,627

)
NET LIABILITIES (41,364 ) (53,698 )

CAPITAL AND RESERVES
Called up share capital 1,020 1,020
Retained earnings (42,384 ) (54,718 )
(41,364 ) (53,698 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)

BALANCE SHEET - continued
31 MAY 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 February 2024 and were signed on its behalf by:





A J Sadeh - Director


ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

1. STATUTORY INFORMATION

Aristo Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 2 ) .

ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2022 3,653
Additions 1,640
At 31 May 2023 5,293
DEPRECIATION
At 1 June 2022 1,642
Charge for year 1,340
At 31 May 2023 2,982
NET BOOK VALUE
At 31 May 2023 2,311
At 31 May 2022 2,011

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 33,020 10,000
Amounts owed by participating interests 39,894 44,843
Other debtors 4,228 1,725
77,142 56,568

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 10,000 11,040
Trade creditors 428 -
Amounts owed to participating interests 29,644 19,831
Taxation and social security 2,715 643
Other creditors 954 954
43,741 32,468

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Bank loans 21,667 30,627
Amounts owed to participating interests 58,000 58,000
79,667 88,627

ARISTO HEALTH LTD (REGISTERED NUMBER: 11972936)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2023

8. RELATED PARTY DISCLOSURES

During the period the company has received funding from ASN Capital Limited, a company in which Mr Sadeh is also a director. The amount provided in the period was £1,699 (2022 - £541). As at the balance sheet date £6,598 (2022 - £4,899) was owed to ASN Capital Limited.

During the period the company has received funding from ASN Capital Investments Limited, a company in which Mr Sadeh is also a director. The amount (repaid) / provided in the period was £(4,949) (2022 - £(2,934)). As at the balance sheet date £39,894 (2022 - £43,047) was owed by / (to) ASN Capital Investments Limited.

In the previous period some of the funds owed to ASN Capital Investments Limited as at 31 May 2022 were converted to a long term subordinated loan. The amount transferred was £nil (2022 - £10,000l) and as at the balance sheet date the amount owed to ASN Capital Investments Limited was £58,000 (2022 - £58,000).

During the period the company has received funding from ASN Capital Lettings Limited, a company in which Mr Sadeh is also a director. The amount provided in the period was £7,700 (2022 - £7,700). As at the balance sheet date £20,155 (2022 - £12,455) was owed to ASN Capital Lettings Limited.

During the period the company has received funding from ASN Capital Project Alpha Limited, a company in which Mr Sadeh is also a director. The amount provided in the period was £nil (2022 - £463). As at the balance sheet date £1,698 (2022 - £1,698) was owed to ASN Capital Project Alpha Limited.

During the period the company has received funding from ASN Capital Construction Limited, a company in which Mr Sadeh is also a director. The amount provided in the period was £415 (2022 - £780). As at the balance sheet date £1,195 (2022 - £780) was owed to ASN Capital Construction Limited.

9. GOING CONCERN

Aristo Health Limited currently has a balance sheet deficit of £41,364 (2022 - £53,698). Although concerning, we believe that with the support of connected companies, the company can continue to trade and reduce the deficit in future periods.